Top Markets
#1 Siren Siren +39.12%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#3 Ocean Protocol Ocean Protocol +15.51%
#4 KUB Coin KUB Coin +15.08%
#5 Perle Perle +11.39%
#6 Audiera Audiera +11.03%
#7 Nockchain Nockchain +9.99%
#8 Geodnet Geodnet +9.30%
#9 Arowana Arowana +8.26%
#10 Wiki Cat Wiki Cat +8.24%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.

INTS
Classement en actions #32096
Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical... Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT230-6, is presently undergoing Phase 2 clinical trials. This investigational drug targets a range of difficult-to-treat solid tumors, including those affecting the pancreas, colon, bile duct, as well as squamous cell, sarcoma, breast, and liver cancers. Intensity Therapeutics has formed strategic collaborations with major pharmaceutical companies and research institutions: A partnership with Merck Sharpe & Dohme Corp. focuses on evaluating INT230-6 in conjunction with Keytruda for advanced pancreatic, colon, squamous cell, and bile duct malignancies. Another collaboration with Bristol-Myers Squibb Company is dedicated to studying INT230-6 combined with Yervoy in patients suffering from advanced liver, breast, and sarcoma cancers. Furthermore, the company is working with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research on a randomized controlled Phase II neoadjuvant study of INT230-6 for women diagnosed with early-stage breast cancer. Established in 2012, Intensity Therapeutics maintains its corporate headquarters in Westport, Connecticut.
Prix de l'action
$4.12
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$11.14M
Changement (1 jour)
4.04%
Changement (1 an)
-45.79%
Pays
US
Échange Intensity Therapeutics, Inc. (INTS)

Catégorie

Healthcare
Le prix INTS avec la capitalisation boursière de B
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
INTS
$4.12
Capitalisation boursière de Intensity Therapeutics, Inc.(INTS)
Capitalisation boursière: $11.14M
En August 2026, Intensity Therapeutics, Inc. a une capitalisation boursière de $11.14M. Cela fait de Intensity Therapeutics, Inc. la 32096th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Intensity Therapeutics, Inc. du 2023 au 2026
INTS par rapport au top 5 des plus populaires stocks
Prix pour INTS L’actif B La capitalisation boursière de B Résultats
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
$2,020,165 $11.14M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.460T +49,033,026.64%
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
$1,661,038 $11.14M
Apple Inc. Apple Inc.
AAPL
$4.489T +40,316,347.71%
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
$1,532,064 $11.14M
Alphabet Inc. Alphabet Inc.
GOOG
$4.141T +37,185,915.71%
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
$1,320,301 $11.14M
Microsoft Corporation Microsoft Corporation
MSFT
$3.569T +32,046,033.17%
Intensity Therapeutics, Inc. Intensity Therapeutics, Inc.
$1,035,226 $11.14M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.798T +25,126,751.65%